PSMD14 and ovarian carcinoma: Enriched proteasome genes, including PSME4 and PSMD14, was exhibited in doxorubicin-derived resistant ovarian cancer cell line, suggesting that this proteasome pathway may be involved in the development of resistance to doxorubicin [96].